We revolutionize cancer diagnostics with cutting-edge technology designed to provide personalized, precise, and efficient insights into cancer treatment responses.

Vega about
Vega about

About
Vega BioImaging

Vega analysis

Resulting from university research, Vega BioImaging was founded to tackle a critical issue in cancer diagnostics: the high rate of companion diagnostic errors (ranging from 7% to 30% depending on the pathology). These errors, driven by a lack of quantitativity, often lead to sub-optimal cancer treatment prescriptions. 


By partnering with healthcare providers and pharmaceutical companies, we aim to enhance patient outcomes and accelerate drug development, delivering tailored treatment strategies that improve survival rates while reducing costs for the healthcare system.

Vega about

Mission

Vega analysis

Our mission is to increase the accuracy of cancer diagnostics to ensure that every patient receives the most appropriate treatment, improving their chances of survival and quality of life during therapy.

Leadership Team

Cécile Darviot, Ph.D.

Co-Founder & CEO
Cécile Darviot
Cécile Darviot, with a background in Engineering Physics and experience in project management, leads Vega BioImaging with a vision to revolutionize cancer diagnostics. Her expertise in microscopy and image processing is pivotal in driving our technological advancements.
LinkedIn

Arnaud Latreille

COO
Arnaud Latreille
Arnaud, a medical student with a passion for entrepreneurship, brings his expertise in medicine and business development to Vega BioImaging. As the Chief Operating Officer, he focuses on market validation and the commercial growth of our innovative diagnostic solutions. His unique combination of medical knowledge and entrepreneurial drive is instrumental in advancing our mission to improve cancer diagnostics and patient care.
LinkedIn

Jennyfer Zapata, Ph.D.

CSO
Jennyfer Zapata
Jennyfer is a PhD with a dual degree in Biomedical Engineering at Polytechnique Montreal and the National Autonomous University of Mexico. As CSO at Vega BioImaging, she leads the company's technology development, specializing in electronic instrumentation, biophotonics, optics, and nanoplasmonics. Her expertise spans applications in gene therapy and laser-based technologies. Jennyfer also chairs the Executive Committee of the Highly Qualified Personnel (HQP) in the Pan-Canadian Nanomedicine Innovation Network (NMIN), and she has extensive experience collaborating with industry and research groups on laser micromachining and laser-matter interaction projects.
LinkedIn

Paul Raynaud, Ph.D.

CIO
Paul Reynaud
Paul Raynaud oversees the development and integration of advanced computational systems. A PhD specializing in Engineering Mathematics, Paul's expertise lies in optimizing algorithms for machine learning and deep learning applications. His work focuses on enhancing computational efficiency through parallelization techniques, crucial for processing large-scale medical data. At Vega, Paul leads the technical strategy, ensuring the seamless functionality of the company’s software solutions, driving innovation, and supporting the overall goal of advancing precision diagnostics.
LinkedIn

Our Advisors

Sergiy Patskovsky, Ph.D.

Co-Founder & Scientific Advisor
Sergiy Patskovsky
With 17 years of research experience at Polytechnique Montréal, Dr. Sergiy Patskovsky is an expert in optical design and the primary inventor of our initial prototypes. He oversees the development and production of our innovative diagnostic tools.
LinkedIn

Michel Meunier, Ph.D.

Co-Founder & Scientific Advisor
Michel Meunier
A professor of Engineering Physics at Polytechnique Montréal, Dr. Michel Meunier brings extensive expertise in biomedical nanotechnology. He initiated the idea of Vega BioImaging in collaboration with Dr. Trudel and maintains vital academic and clinical partnerships.
LinkedIn

Dominique Trudel, M.D. Ph.D.

Scientific Advisor
Dominique Trudel
An Associate Professor and researcher at the University of Montreal, Dr. Dominique Trudel's expertise lies in histopathological research and the optical characterization of tissues. Her team supervises the application of our diagnostic platform in clinical settings.
LinkedIn

Étienne Crevier, MBA

MBA, Business Advisor
Étienne Crevier
Étienne Crevier is a geneticist and biochemist with extensive experience in clinical and basic research. He combines this scientific expertise with business and administrative training, having 15 years of laboratory research experience and a strong business network in Quebec and Canada. Étienne is a specialist in management and marketing, with a focus on developing healthcare and biotechnology businesses, as well as B2B and B2C sales. He has deep knowledge of the applied academic research community and substantial experience with governmental records related to Quebec and Canada.
LinkedIn

Roula Albadine, M.D.

Scientific Advisor
Dr. Roula Albadine
An Associate Professor at Université de Montréal and a pathologist at CHUM, Dr. Roula Albadine specializes in cytological analyses. She focuses on the clinical validation of our technology, ensuring its efficacy and adoption by healthcare professionals.
LinkedIn